Neuralstem completes sale of stock

Neuralstem Inc., of Rockville, which develops products to treat central nervous system disorders with patented stem cell technology, announced the closing of a $20 million registered direct placement of approximately 6.87 million shares of common stock at a price of $2.91 per share.

Leave a Reply

Your email address will not be published. Required fields are marked *